4.7 Review

Unraveling the role of Mg++ in osteoarthritis

Journal

LIFE SCIENCES
Volume 147, Issue -, Pages 24-29

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.lfs.2016.01.029

Keywords

Magnesium; Osteoarthritis; Inflammatory mediators; Matrix GLA protein (MGP); N-methyl-D-aspartate (NMDA) receptor; Calcium

Funding

  1. National Natural Science Foundation of China [81101344/HO604]
  2. outstanding young talent-training plan of Tenth People's Hospital, Shanghai Tongji University School of Medicine [11RQ104]
  3. Climb talent-training plan of Tenth People's Hospital, Shanghai Tong Ji University School of Medicine [04.01.13023]
  4. Fundamental Research Funds for the Central Universities [1501219095]

Ask authors/readers for more resources

Mg++ is widely involved in human physiological processes that may play key roles in the generation and progression of diseases. Osteoarthritis (OA) is a complex joint disorder characterized by articular cartilage degradation, abnormal mineralization and inflammation. Magnesium deficiency is considered to be a major risk factor for OA development and progression. Magnesium deficiency is active in several pathways that have been implicated in OA, including increased inflammatory mediators, cartilage damage, defective chondrocyte biosynthesis, aberrant calcification and a weakened effect of analgesics. Abundant in vitro and in vivo evidence in animal models now suggests that the nutritional supplementation or local infiltration of Mg++ represent effective therapies for OA. The goal of this review is to summarize the current understanding of the role of Mg++ in OA with particular emphasis on the related molecular mechanisms involved in OA progression. (C) 2016 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available